| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 03/15/2007 | US20070060587 Indane derivates as muscarinic receptor agonists |
| 03/15/2007 | US20070060574 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 03/15/2007 | US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction |
| 03/15/2007 | US20070060569 Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors |
| 03/15/2007 | CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 03/14/2007 | EP1761495A2 Piperidinyl prostaglandin analogs as ocular hypotensive agents |
| 03/14/2007 | EP1761494A1 Chemical compounds i |
| 03/14/2007 | EP1761493A2 Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/14/2007 | EP1761492A1 1-benzyl-4-¬(5,6-dimethoxy-1-indanone)-2-yl| methyl piperidine oxalate (donepezil oxalate) and its polymorphs |
| 03/14/2007 | EP1761491A1 Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor ccr5 |
| 03/14/2007 | EP1511728B1 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 03/14/2007 | EP1242083B1 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
| 03/14/2007 | EP1040103B1 Anilide derivative, production and use thereof |
| 03/14/2007 | EP1019388B1 Preparation of perylene-3,4-dicarboxylic anhydrides |
| 03/14/2007 | CN1930139A Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 03/14/2007 | CN1930125A Biphenyl compounds useful as muscarinic receptor antagonists |
| 03/14/2007 | CN1927865A Synthesis method of thienotetrahydropyridine acetonitrile |
| 03/14/2007 | CN1927837A Process for preparing amlodipine benzenesulphonate |
| 03/14/2007 | CN1927836A Resolution method of optically active amlodipine |
| 03/14/2007 | CN1304691C Chlorohydrin and cationic compounds having high affinity for pulp paper |
| 03/14/2007 | CN1304391C Preparation method of hydrobromic acid antifebrile dichroanone |
| 03/14/2007 | CN1304371C Heterocyclically substituted benzoylureas, their pharmaceuticals and use of preparing pharmaceuticals |
| 03/14/2007 | CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 03/13/2007 | US7189757 Sleep disorders; side effect reduction |
| 03/13/2007 | US7189742 For therapy of disorder associated with elevated levels of 5-HT (5-hydroxytryptamine; serotonin) resultant from newly synthesised 5-HT, anxiety, depression, migraine and sleep apnoea |
| 03/13/2007 | US7189738 Substituted isoindoles and their use thereof |
| 03/13/2007 | CA2376540C Process for preparing amlodipine benzenesulphonate |
| 03/13/2007 | CA2295106C 3-anilino-2-cycloalkenone derivatives |
| 03/13/2007 | CA2208522C Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents |
| 03/08/2007 | WO2007028073A2 Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders |
| 03/08/2007 | WO2007026966A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | WO2007026312A1 1,3-diaminobenzene derivatives and colorants comprising these compounds |
| 03/08/2007 | WO2007025709A2 Organic compounds |
| 03/08/2007 | WO2007025575A1 O-hydroxy- and o-amino benzamide derivatives as ikk2 inhibitors |
| 03/08/2007 | WO2007003962A3 Gpcr agonists |
| 03/08/2007 | WO2007000001A3 Pleuromutilin salts with salicylic acid, azelaic acid, sebacic acid and diclofenac |
| 03/08/2007 | US20070055081 Processes for production of alpha-aminooxyketones and alpha-hydroxyketones |
| 03/08/2007 | US20070055065 3-amidinophenylalanine derivatives such as N-(2-aminoethyl)-1-[(2S)-3-(3-carbamimidoylphenyl)-2-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]propanoyl]piperidine-4-carboxamide, used as inhibitors of matriptase, for the prophylaxis of tumors |
| 03/08/2007 | US20070054935 Novel pyridine derivatives as potassium ion channel openers |
| 03/08/2007 | US20070054931 Preparation of benzoylalkyl-1,2,3,6-tetrahydropyridines and use thereof |
| 03/08/2007 | US20070054924 Novel piperidines as chemokine modulators (ccr) |
| 03/08/2007 | US20070054917 Piperazine derivates and their use for the treatment of neurological and psychiatric diseases |
| 03/08/2007 | US20070054909 VLA-4 inhibitor compounds |
| 03/08/2007 | US20070054888 Novel substituted diamine derivatives useful as motilin agonists |
| 03/08/2007 | CA2620742A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | CA2620222A1 Organic compounds |
| 03/07/2007 | EP1760073A1 Sulfonamide compound |
| 03/07/2007 | EP1760072A1 1,3-diaminobenzene derivatives and colorants comprising these compounds |
| 03/07/2007 | EP1758882A1 Amido compounds and their use as pharmaceuticals |
| 03/07/2007 | EP1758858A1 Cosmetic use of piperidine derivatives |
| 03/07/2007 | EP1758583A2 Arylpiperazine derivatives useful as adrenergic receptor antagonists |
| 03/07/2007 | EP1758580A2 N-substituted piperidines and their use as pharmaceuticals |
| 03/07/2007 | EP1372651B1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity |
| 03/07/2007 | EP1187811B1 Inhibitors of metalloproteinases |
| 03/07/2007 | EP1061922B9 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 03/07/2007 | CN1926107A Weakly basic hindered amines having carbonate skeletons, synthetic resin compositions, and coating compositions |
| 03/07/2007 | CN1926106A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 03/07/2007 | CN1926105A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 03/07/2007 | CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/06/2007 | US7186842 Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof |
| 03/06/2007 | US7186834 Substituted iminoazines |
| 03/06/2007 | US7186827 Dipeptide synthesis |
| 03/06/2007 | US7186737 Inhibitors of p38 |
| 03/06/2007 | US7186733 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | US7186726 Preferentially substituted calcium channel blockers |
| 03/06/2007 | US7186725 Anti-inflammatory compositions and methods |
| 03/06/2007 | US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
| 03/06/2007 | US7186719 Antibacterial agents |
| 03/06/2007 | CA2200355C Crystallisation of levobupivacaine and analogues thereof |
| 03/01/2007 | WO2007023882A1 Derivative having ppar agonistic activity |
| 03/01/2007 | WO2005117882A9 Hydroxamic acid derivatives as metalloprotease inhibitors |
| 03/01/2007 | US20070049566 Methods and Compositions for inhibition of angiogenesis |
| 03/01/2007 | US20070048728 Hydroxylases and modulators thereof |
| 03/01/2007 | CA2621164A1 Derivative having ppar agonistic activity |
| 02/28/2007 | EP1757583A1 Process for producing cyclic n-hydroxyimide compound |
| 02/28/2007 | EP1757582A1 Arylalkylamines and process for production thereof |
| 02/28/2007 | EP1756107A2 Aryl-substituted piperazine derivatives |
| 02/28/2007 | EP1756106A1 Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/28/2007 | EP1756101A2 Androgen receptor modulators and method of treating disease using the same |
| 02/28/2007 | EP1756063A1 Amido compounds and their use as pharmaceuticals |
| 02/28/2007 | EP1756058A1 Histamine-3 receptor antagonists |
| 02/28/2007 | EP1756044A1 Therapeutic compounds |
| 02/28/2007 | EP1756037A2 Amino alcohol derivatives and their activity as renin inhibitors |
| 02/28/2007 | EP1755593A1 Naphthaline derivatives useful as histamine-3-receptor ligands |
| 02/28/2007 | EP1343561B1 Serine protease inhibitors |
| 02/28/2007 | EP1275645B1 Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system |
| 02/28/2007 | EP1265606B9 Cell adhesion inhibitors |
| 02/28/2007 | EP1240154B1 Serine protease inhibitors |
| 02/28/2007 | EP1049674B1 Method for producing (-)cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-piperidine |
| 02/28/2007 | CN1922177A Aryl- and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of FAAH enzyme inhibitors |
| 02/28/2007 | CN1922138A Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 02/28/2007 | CN1921863A 免疫抑制剂化合物和组合物 Immunosuppressant compounds and compositions |
| 02/28/2007 | CN1921858A Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors |
| 02/28/2007 | CN1302060C Novel flame retarding compounds |
| 02/28/2007 | CN1302002C Hydroxylamine esters as polymerization initiators |
| 02/28/2007 | CN1301991C Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
| 02/28/2007 | CN1301972C Piperidine compounds as muscarinic antagonists |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/27/2007 | US7183447 Preparation of ring compounds via a combinatorial synthesis based on a Suzuki coupling, subsequent halo-demetallation and finally a Suzuki coupling; Suzuki couplings are each carried out with a boronic acid or a boronic acid ester |